Next Article in Journal
Oligomerization of 10,16-Dihydroxyhexadecanoic Acid and Methyl 10,16-Dihydroxyhexadecanoate Catalyzed by Lipases
Next Article in Special Issue
DNA Condensation by Partially Acetylated Poly(amido amine) Dendrimers: Effects of Dendrimer Charge Density on Complex Formation
Previous Article in Journal
Anti-Oxidant and Anti-Inflammatory Activities of Inonotus obliquus and Germinated Brown Rice Extracts
Previous Article in Special Issue
The Effect of PAMAM Dendrimers on the Antibacterial Activity of Antibiotics with Different Water Solubility
Article Menu

Export Article

Open AccessArticle
Molecules 2013, 18(8), 9305-9316; doi:10.3390/molecules18089305

An Azabisphosphonate-Capped Poly(phosphorhydrazone) Dendrimer for the Treatment of Endotoxin-Induced Uveitis

INSERM, U1043, CNRS, U5282, Université de Toulouse, UPS, Centre de Physiopathologie de Toulouse-Purpan, Toulouse F-31300, France
CNRS, LCC (Laboratoire de Chimie de Coordination) 205 route de Narbonne, BP 44099, F-31077 Toulouse cedex 4, France
Solid Drug Development SA, 8 rue John Grasset, Geneva CH-1205, Switzerland
Authors to whom correspondence should be addressed.
Received: 15 July 2013 / Revised: 26 July 2013 / Accepted: 1 August 2013 / Published: 5 August 2013
(This article belongs to the Special Issue Dendrimers in Medicine and Biotechnology)
View Full-Text   |   Download PDF [871 KB, uploaded 18 June 2014]   |  


Over the last decade, different types of dendrimers have shown anti-inflammatory properties in their own right. In particular, we have shown that poly(phosphorhydrazone) (PPH) dendrimers are able to foster an efficient anti-inflammatory response in human monocytes and can resolve the main physiopathological features of chronic arthritis in mice at 1 mg/kg. Here we afford new insights into the therapeutic potential of an azabisphosphonate-capped dendrimer (dendrimer ABP). We have challenged its anti-inflammatory and immuno-modulatory properties in a robust rat model of acute uveitis induced by lipopolysaccharide (LPS). We show that dendrimer ABP at 2 µg/eye is as efficient as the “gold standard” dexamethasone at 20 µg/eye. We have demonstrated that the effect of dendrimer ABP is mediated at least through an increase of the production of the anti-inflammatory Interleukin(IL)-10 cytokine.
Keywords: PPH [poly(phosphorhydrazone)] dendrimer; anti-inflammatory; uveitis; toxicity PPH [poly(phosphorhydrazone)] dendrimer; anti-inflammatory; uveitis; toxicity
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Fruchon, S.; Caminade, A.-M.; Abadie, C.; Davignon, J.-L.; Combette, J.-M.; Turrin, C.-O.; Poupot, R. An Azabisphosphonate-Capped Poly(phosphorhydrazone) Dendrimer for the Treatment of Endotoxin-Induced Uveitis. Molecules 2013, 18, 9305-9316.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top